Amyloid fibrils of human prion protein are spun and woven from morphologically disordered aggregates

References

• Westermark P. Aspects on human amyloid forms and their fibril polypeptides. The FEBS journal 2005; 272:5942 - 5949
   PubMed Web of Science ®Google Scholar
• Chiti F, Dobson CM. Protein misfolding, functional amyloid and human disease. Ann Rev Biochem 2006; 75:333 - 366
   PubMed Web of Science ®Google Scholar
• Mishra R, Sorgjerd K, Nystrom S, Nordigarden A, Yu YC, Hammarstrom P. Lysozyme amyloidogenesis is accelerated by specific nicking and fragmentation but decelerated by intact protein binding and conversion. J Mol Biol 2007; 366:1029 - 1044
   PubMed Web of Science ®Google Scholar
• Liberski PP. Amyloid plaques in transmissible spongiform encephalopathies (prion diseases). Folia neuropathologica 2004; 42:109 - 119
   Google Scholar
• Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216:136 - 144
   PubMed Web of Science ®Google Scholar
• Prusiner SB, McKinley MP, Bowman KA, Bolton DC, Bendheim PE, Groth DF, Glenner GG. Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 1983; 35:349 - 358
   PubMed Web of Science ®Google Scholar
• Aguzzi A. Staining, straining and restraining prions. Nat Neurosci 2008; 11:1239 - 1240
   PubMed Web of Science ®Google Scholar
• Sigurdson CJ, Nilsson KP, Hornemann S, Manco G, Polymenidou M, Schwarz P, et al. Prion strain discrimination using luminescent conjugated polymers. Nat Meth 2007; 4:1023 - 1030
   PubMed Web of Science ®Google Scholar
• Zahn R, Liu A, Luhrs T, Riek R, von Schroetter C, Lopez Garcia F, et al. NMR solution structure of the human prion protein. Proc Natl Acad Sci USA 2000; 97:145 - 150
   PubMed Web of Science ®Google Scholar
• Kaneko K, Ball HL, Wille H, Zhang H, Groth D, Torchia M, et al. A synthetic peptide initiates Gerstmann-Straussler-Scheinker (GSS) disease in transgenic mice. J Mol Biol 2000; 295:997 - 1007
   PubMed Web of Science ®Google Scholar
• Legname G, Baskakov IV, Nguyen HO, Riesner D, Cohen FE, DeArmond SJ, Prusiner SB. Synthetic mammalian prions. Science 2004; 305:673 - 676
   PubMed Web of Science ®Google Scholar
• Nilsson KP, Herland A, Hammarstrom P, Inganas O. Conjugated polyelectrolytes: conformation-sensitive optical probes for detection of amyloid fibril formation. Biochemistry 2005; 44:3718 - 3724
   PubMed Web of Science ®Google Scholar
• Nilsson KP, Hammarstrom P, Ahlgren F, Herland A, Schnell EA, Lindgren M. Conjugated polyelectrolytes—conformation-sensitive optical probes for staining and characterization of amyloid deposits. Chembiochem 2006; 7:1096 - 1104
   PubMed Web of Science ®Google Scholar
• Nilsson KP, Aslund A, Berg I, Nystrom S, Konradsson P, Herland A, et al. Imaging distinct conformational states of amyloid-beta fibrils in Alzheimer's disease using novel luminescent probes. ACS Chem Biol 2007; 2:553 - 560
   PubMed Web of Science ®Google Scholar
• Aslund A, Herland A, Hammarstrom P, Nilsson KP, Jonsson BH, Inganas O, Konradsson P. Studies of luminescent conjugated polythiophene derivatives: enhanced spectral discrimination of protein conformational states. Bioconjugate chemistry 2007; 18:1860 - 1868
   PubMed Web of Science ®Google Scholar
• Gregersen N. Protein misfolding disorders: pathogenesis and intervention. J Inher Metabolic Dis 2006; 29:456 - 470
   PubMed Web of Science ®Google Scholar
• Stohr J, Weinmann N, Wille H, Kaimann T, Nagel-Steger L, Birkmann E, et al. Mechanisms of prion protein assembly into amyloid. Proc Natl Acad Sci 2008; 105:2409 - 2414
   PubMed Web of Science ®Google Scholar
• Baskakov IV, Legname G, Baldwin MA, Prusiner SB, Cohen FE. Pathway complexity of prion protein assembly into amyloid. J Biol Chem 2002; 277:21140 - 21148
   PubMed Web of Science ®Google Scholar
• Bocharova OV, Breydo L, Parfenov AS, Salnikov VV, Baskakov IV. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc). J Mol Biol 2005; 346:645 - 659
   PubMed Web of Science ®Google Scholar
• Luhrs T, Zahn R, Wuthrich K. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions. J Mol Biol 2006; 357:833 - 841
   PubMed Web of Science ®Google Scholar
• Apetri AC, Vanik DL, Surewicz WK. Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein 90–231. Biochemistry 2005; 44:15880 - 15888
   PubMed Web of Science ®Google Scholar
• Cobb NJ, Apetri AC, Surewicz WK. Prion Protein Amyloid Formation under Native-like Conditions Involves Refolding of the C-terminal {alpha}-Helical Domain. J Biol Chem 2008; 283:34704 - 34711
   PubMed Web of Science ®Google Scholar
• Chesler M. Regulation and modulation of pH in the brain. Physiological Rev 2003; 83:1183 - 1221
   PubMed Web of Science ®Google Scholar
• Zahn R. The octapeptide repeats in mammalian prion protein constitute a pH-dependent folding and aggregation site. J Mol Biol 2003; 334:477 - 488
   PubMed Web of Science ®Google Scholar
• Knaus KJ, Morillas M, Swietnicki W, Malone M, Surewicz WK, Yee VC. Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nat Struct Biol 2001; 8:770 - 774
   PubMedGoogle Scholar
• Perriman AW, Henderson MJ, Holt SA, White JW. Effect of the air-water interface on the stability of beta-lactoglobulin. J Phys Chem 2007; 111:13527 - 13537
   PubMed Web of Science ®Google Scholar
• Sigurdson CJ, Nilsson KP, Hornemann S, Heikenwalder M, Manco G, Schwarz P, et al. De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis. Proc Natl Acad Sci 2009; 106:304 - 309
   PubMed Web of Science ®Google Scholar
• Nozaki Y. The preparation of guanidine hydrochloride. Meth Enzymol 1972; 26:43 - 50
   PubMedGoogle Scholar
• Zahn R, von Schroetter C, Wuthrich K. Human prion proteins expressed in Escherichia coli and purified by high-affinity column refolding. FEBS Letters 1997; 417:400 - 404
   PubMed Web of Science ®Google Scholar
• Sjoberg AP, Nystrom S, Hammarstrom P, Blom AM. Native, amyloid fibrils and beta-oligomers of the C-terminal domain of human prion protein display differential activation of complement and bind C1q, factor H and C4b-binding protein directly. Mol Immunol 2008; 45:3213 - 3221
   PubMed Web of Science ®Google Scholar
• Ding L, Jonforsen M, Roman LS, Andersson M, Inganäs O. Photovoltaic cells with a conjugated poly electrolyte. Synth Meth 2000; 110:133 - 140
   Web of Science ®Google Scholar